Table 3_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 8_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 6_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 5_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 4_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 7_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Data Sheet 1_Impact of mini-dose dexmedetomidine supplemented analgesia on sleep structure in patients at high risk of obstructive sleep apnea: a pilot trial.docx by Pei Sun (115160)

“…Mini-dose dexmedetomidine supplemented analgesia increased the percentage of stage N2 sleep (median difference, 10%; 95% CI, 1 to 21%; p = 0.029); it also decreased the percentage of stage N1 sleep (median difference, −10%; 95% CI, −20% to −1%; p = 0.042). …”

Data Sheet 2_Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis.zip by Junhuang Zheng (21629486)

“…</p>Results<p>This meta-analysis included 11 studies. High LNR was significantly associated with decreased overall survival (OS) (multivariable HR=1.76, 95% CI=1.36-2.27; univariable HR=2.26, 95% CI=1.95-2.63) and increased risk of shorter disease-free survival (DFS) (multivariable HR=1.66, 95% CI=1.48-1.88). …”

Data Sheet 1_Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis.zip by Junhuang Zheng (21629486)

“…</p>Results<p>This meta-analysis included 11 studies. High LNR was significantly associated with decreased overall survival (OS) (multivariable HR=1.76, 95% CI=1.36-2.27; univariable HR=2.26, 95% CI=1.95-2.63) and increased risk of shorter disease-free survival (DFS) (multivariable HR=1.66, 95% CI=1.48-1.88). …”

Data Sheet 1_Spleen tyrosine kinase inhibition mitigates radiation-induced lung injury through anti-inflammatory effects and downregulation of p38 MAPK and p53.pdf by Guoxing Zhang (4994213)

“…Syk was highly expressed in irradiated lung tissue, and fostamatinib inhibited the level of Syk expression. Syk inhibitor significantly alleviated the radiation-induced lung injury and downregulated the increased expression of p38 MAPK, p53, IL-1β, and IL-6 in lung tissue at 2 weeks after radiation. …”

Spectral shift of fluorophore NHS-esters. by Hyunwoo Kim (690467)

“…After 5 min of illumination with a 561-nm excitation laser, the fluorescence signal in the 647-nm detection channel decreased, while the signal in the 561-nm detection channel significantly increased, indicating a spectral blue-shift of the emission spectrum. …”

Data Sheet 8_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 5_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 7_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 3_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Table 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.xlsx by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 6_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Impact of mobility in a three-region system with heterogeneous epidemic conditions. by Mousumi Roy (8869412)

“…From left to right, we consider the scenarios with decreasing outgoing mobility and increasing non-commuting population. …”

Data Sheet 2_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”